Lv5
1480 积分 2024-07-23 加入
New insights into the immunopathogenesis of systemic lupus erythematosus
6天前
已完结
Engineering challenges and translational opportunities in emerging gene delivery platforms
12天前
已完结
Efficacy and Safety of Chimeric Antigen Receptor T Cell Immunotherapy in B-Cell Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
21天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
Progress in the development of cytokine armoured CAR T cells
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
3个月前
已完结
The dawn of in vivo immune cell engineering in oncology
3个月前
已完结
An IL-12 renaissance: Engineering tumor-restricted IL-12 to improve solid tumor T cell therapies
4个月前
已完结
Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death
4个月前
已完结
皖公网安备34019202002308
